Miller Thomson LLP requests that their press release NewsItemId: 20210120005542 “Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units” be killed.
The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations Group.
Mydecine Innovations Group Media Contacts
Anne Donohoe / Nick Opich
KCSA Strategic Communications
[email protected] / [email protected]
212-896-1265 / 212-896-1206
On behalf of the Board of Directors:
Joshua Bartch, Chief Executive Officer
[email protected]
Corp Communications:
Charles Lee, Investor Relations
[email protected]
+1 720-277-9879